n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Osteoarthritis, Knee in 1 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Osteoarthritis, Knee: Noninflammatory degenerative disease of the knee joint consisting of three large categories: conditions that block normal synchronous movement, conditions that produce abnormal pathways of motion, and conditions that cause stress concentration resulting in changes to articular cartilage. (Crenshaw, Campbell's Operative Orthopaedics, 8th ed, p2019)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
LeGrand, A | 1 |
Fermor, B | 1 |
Fink, C | 1 |
Pisetsky, DS | 1 |
Weinberg, JB | 1 |
Vail, TP | 1 |
Guilak, F | 1 |
1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Osteoarthritis, Knee
Article | Year |
---|---|
Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci.
Topics: Aged; Amidines; Benzylamines; Cell Survival; Cells, Cultured; Cyclooxygenase Inhibitors; Cytokines; | 2001 |